Cancer gene family member functions key to cell adhesion and migration

August 30, 2012
Here you see wildtype cells stained for the actin cytoskeleton in blue, tubulin protein in red, and the nucleus in dark blue. Compared to wildtype cells on the left, removal of FAM123A results in a dramatically condensed actin network and kidney shaped nuclei. Credit: Ben Major, Ph.D., the University of North Carolina at Chapel Hill

The WTX gene is mutated in approximately 30 percent of Wilms tumors, a pediatric kidney cancer. Like many genes, WTX is part of a family. In this case, WTX has two related siblings, FAM123A and FAM123C. While cancer researchers are learning more of WTX and how its loss contributes to cancer formation, virtually nothing is known of FAM123C or FAM123A, the latter of which is a highly abundant protein within neurons, cells that receive and send messages from the body to the brain and back to the body.

A UNC-led team of scientists used sophisticated technologies to identify and describe the protein interactions that distinguish each member of the WTX family. They found that unlike WTX and FAM123C, FAM123A interacts with a specific set of proteins that regulates cell adhesion and migration, processes essential to normal cell functioning and which, when mutated, contribute to human diseases such as cancer or Alzheimer's.

The report is the first to associate a member of the WTX with cell adhesion and migration. Ben Major, PhD, and his research team believe that because FAM123A is so highly expressed in neurons, their findings raise the possibility that FAM123A controls neuron migration and , both of which play critical roles in development, neuro-degeneration and learning. Dr. Major, study senior author, is an assistant professor of and physiology in the UNC School of Medicine and a member of UNC Lineberger Comprehensive Cancer Center.

Their report appears in the September 4, 2012 online edition of Science Signaling.

The white areas represent the localization of FAM123A in living cells which are migrating on a surface. Most of the FAM123A in cells resides at the periphery. However, the white streaks within the cell body demonstrate that FAM123A also localizes to the microtubule cytoskeleton, and specifically those microtubules that point in the direction of cell movement.

The specific set of proteins the scientists discovered within the FAM123A complex are known microtubules-associated proteins. Microtubules, one component of a cell's , are rigid hollow rods approximately 25 nm in diameter, about 3000 times thinner than a human hair. Microtubules are dynamic structures that undergo continual assembly and disassembly within the cell. They function both to determine cell shape and to control a variety of cell movements, including some forms of cell locomotion.

Here you see the movement of the FAM123A protein in living cells. Notice that the green dots move in linear pathway toward the cell edge. When we mutated specific amino acids within FAM123A necessary for binding a protein called EB1, the protein no longer associates with or moves on microtubules.

Dr. Major explains, "Since FAM123A and WTX are closely related proteins, anything we learn about FAM123A helps us know more about WTX, the tumor suppressor gene lost in cancer. Unlike WTX, FAM123A binds to a specific set of proteins that are famous for regulating microtubules, a critical component within the cell's cytoskeleton or cellular 'scaffolding.' It's important to understand how different cellular cytoskeletal networks communicate and coordinate with each other. This communication is required for normal development and life.

"When the cytoskeleton is not functioning properly, a myriad of diseases arise, including certain cancers and cancer metastases. In cancer, cells can't move to new areas of the body without being able to squeeze between and crawl around surrounding cells and tissues, which ultimately allows the cell to move away from the primary tumor. Such movement requires complicated and intricate coordination between the cytoskeleton and the rest of the cell. Our work shows that FAM123A is critical for this communication."

Dr. Major and his research team use a powerful new technology to study protein complexes. He says, "Proteins never work alone, rather they bind each other to collectively carry out a specific task. An important challenge in cancer research today is determining which of the more than 30,000 proteins in a cell come together to form complexes." Dr. Major and colleagues can purify a specific protein from cells and then, using sophisticated technologies called mass spectrometry, they identify the associated proteins.

Explore further: UNC scientists describe protein that protects against colon cancer

Related Stories

UNC scientists describe protein that protects against colon cancer

April 18, 2012
A family of proteins is yielding new information about how it contributes to the development of gastrointestinal disease and cancer. A team of UNC scientists reports that in pre-clinical models, the absence of a protein called ...

Protein associated with childhood cancer alters the structure of DNA, leading to cancer

November 18, 2011
UNC scientists have demonstrated for the first time how a critical gene associated with a type of childhood cancer alters the way DNA is packaged in cells and leads to cancer. Their laboratory discovery could result in the ...

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.